Evidence map›Paper›PMID 38549030›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Deep Learning-Assisted Analysis of Immunopeptidomics Data.

Wassim Gabriel, Mario Picciani, Matthew The, Mathias Wilhelm

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wassim GabrielComputational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Mario PiccianiComputational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Matthew TheChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Mathias WilhelmComputational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. mathias.wilhelm@tum.de.
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid chromatography-coupled mass spectrometry (LC-MS/MS) is the primary method to obtain direct evidence for the presentation of disease- or patient-specific human leukocyte antigen (HLA). However, compared to the analysis of tryptic peptides in proteomics, the analysis of HLA peptides still poses computational and statistical challenges. Recently, fragment ion intensity-based matching scores assessing the similarity between predicted and observed spectra were shown to substantially increase the number of confidently identified peptides, particularly in use cases where non-tryptic peptides are analyzed. In this chapter, we describe in detail three procedures on how to benefit from state-of-the-art deep learning models to analyze and validate single spectra, single measurements, and multiple measurements in mass spectrometry-based immunopeptidomics. For this, we explain how to use the Universal Spectrum Explorer (USE), online Oktoberfest, and offline Oktoberfest. For intensity-based scoring, Oktoberfest uses fragment ion intensity and retention time predictions from the deep learning framework Prosit, a deep neural network trained on a very large number of synthetic peptides and tandem mass spectra generated within the ProteomeTools project. The examples shown highlight how deep learning-assisted analysis can increase the number of identified HLA peptides, facilitate the discovery of confidently identified neo-epitopes, or provide assistance in the assessment of the presence of cryptic peptides, such as spliced peptides.

Indexed as

Deep LearningChromatography, LiquidHistocompatibility Antigens Class IHLA AntigensHumansPeptidesTandem Mass SpectrometryHistocompatibility Antigens Class IHLA AntigensPeptidesDeep learningImmunopeptidomicsMass spectrometryPeptide identificationPrositRescoringVisualizations

Identifiers

PMID38549030
OpenAlexW4393285700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.